Company Profile
Updated: 17-SEP-093-J Fuels Inc.
Private Company, Headquarters Location
61 W Service Rd., Champlain, NY 12919-4438, United States
(518)298-2555, (518)298-2372 fax,
Primary SIC: Trucking, Except Local, Primary NAICS: General Freight Trucking, Long-Distance, Truckload
Description: Transportation: Long-distance trucking.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
B/E Aerospace Reports Third Quarter 2009 Financial Results; EPS $0.36 Per Share; Confirms 2009 Guidance, Provides 2010 Outlook.(Financial report)
Defense & Aerospace Week; 11/11/2009; 1380 words; ...compared with a $7.3 million positive impact...revenues, a $78.3 million, or 26.0...operating earnings by $7.3 million compared to...performance, Amin J. Khoury, Chairman...of B/E Aerospace, Inc. said, "The global...to suffer from high fuel costs, weak demand...
Portec Rail Products, Inc. Reports 2009 Third Quarter and Nine Month Operating Results unaudited.(Financial report)
Information Technology Newsweekly; 11/10/2009; 1348 words; Portec Rail Products, Inc. (NASDAQ:PRPX) announced...September 30, 2009 were $24.3 million and $73.0 million...respectively. Richard J. Jarosinski, President...asset life and reducing fuel costs. Our global customer...Portec Rail Products, Inc., headquartered in Pittsburgh...
DayStar Technologies Announces Appointment of Richard C. Green, Jr. to Board of Directors.
PR Newswire; 11/9/2009; 1081 words; ...DayStar Technologies, Inc. , a developer of...revenues of $36.3 billion. Mr. Green...power, alternative fuels, energy efficiency...DayStar Technologies, Inc. DayStar Technologies, Inc. is engaged in the...Steckel Patrick J. Forkin III CEO...
Goldsource Announces Initial Border Coal Resource.
Marketwire Canada; 11/9/2009; 3321 words; ...Goldsource Mines Inc. (the "Company...included in the resource. J. Scott Drever, President...characteristics and potential to fuel a major, modern, clean...Niska Niska 108 3.3:1 - 66,100,000...Niska Niska 107 4.3:1 - 23,500,000...
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI).
PR Newswire; 11/9/2009; 1120 words; ...ISTA Pharmaceuticals, Inc. , today announced...solution) 1.5% Phase 3 clinical studies...results from two Phase 3 studies demonstrated...greater than or equal to 3 at screening during...of the poster were J. I. Williams, J...product pipeline to fuel future growth and market...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning